Clinical Trials Logo

Clinical Trial Summary

Specific Aims: The primary objective of this registry is to determine the percentage of patients who are free from atrial fibrillation (AF) at 6 and 12 months following a surgical ablation procedure when the patient has a history of failing one or more previous catheter based ablations for AF. The first 3 months following surgical ablation will be a blanking period; any arrhythmia occurring during this time will not be used to determine success.

Primary Objectives:

1. Determine the percent success of surgical ablation for AF at 6, and 12 months both on and off of antiarrhythmic drugs (AAD) following a failed catheter based ablation for AF

2. Record and evaluate all complications associated with the surgical procedure.

Secondary Objectives:

1. Evaluate usage of anticoagulants at 6, and 12 months.

2. Determine the percentage of Pulmonary Veins (PV) that were electrically isolated by intra-operative, pre-surgical mapping


Clinical Trial Description

n/a


Study Design

Observational Model: Case-Only, Time Perspective: Retrospective


Related Conditions & MeSH terms


NCT number NCT01034852
Study type Observational
Source Cardiopulmonary Research Science and Technology Institute
Contact
Status Completed
Phase N/A
Start date May 2009
Completion date January 2011

See also
  Status Clinical Trial Phase
Completed NCT03148236 - Vitamin C in Atrial Fibrillation Ablation Phase 2
Recruiting NCT06291506 - SUbstrate Ablation in Persistent Atrial Fibrillation for Elimination of Recurrences (SUPAFER). N/A
Completed NCT05086861 - Oesophageal Pacing to Check Left Atrial Posterior Wall Isolation N/A
Recruiting NCT00773539 - A Prospective Randomized Study Comparing Radiofrequency Energy With Cryoenergy Phase 4
Completed NCT01730924 - Comparison of Pulmonary Vein Isolation Using SmartTouch® Catheter With or Without Real-time Contact Force Data N/A